Xylocaine Injection, Solution
Product Images NDC 65219-812

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 65219-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xyl03 0001 01

Chemical structure of lidocaine hydrochloride, the active ingredient in Xylocaine MPF injection solution, illustrating its molecular framework including aromatic rings, amide, and amine groups, with attached hydrochloride (HCl).*

FDA Label Image

Xyl03 0001 02

Chemical structure diagram of lidocaine hydrochloride, the active ingredient in Xylocaine MPF injection. The structure shows a benzene ring with hydroxyl groups and an attached side chain including an amine group.*

FDA Label Image

Xyl03 0001 03

FDA Label Image

Xyl03 0001 04

Label for Xylocaine MPF injection solution, containing lidocaine hydrochloride at 1% strength (20 mg per 2 mL or 10 mg per mL). The vial size is 2 mL single dose. It is indicated for infiltration and nerve block, including caudal and epidural use. The labeler is Fresenius Kabi USA, LLC, located in Lake Zurich, Illinois.*

FDA Label Image

Xyl03 0001 05

Label for Xylocaine-MPF (lidocaine hydrochloride injection, USP) 20 mg per 2 mL (10 mg/mL) solution. It is a 1% injection solution for infiltration and nerve block including caudal and epidural use. The package contains 25 single-dose vials of 2 mL each. Manufactured by Fresenius Kabi USA, LLC. The label includes storage instructions, usage warnings, and barcode.*

FDA Label Image

Xyl03 0001 06

Label for Xylocaine-MPF (lidocaine HCl injection, USP) 2% solution, 100 mg per 5 mL (20 mg per mL) in a 5 mL single dose vial. The label indicates use for infiltration and nerve block, including caudal and epidural administration. It is methylparaben free, sterile, nonpyrogenic, and manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Xyl03 0001 07

Label for Xylocaine-MPF Injection, USP, 2% lidocaine hydrochloride solution, 20 mg/mL strength. The label indicates a 5 mL single-dose vial with 100 mg per vial, intended for infiltration and nerve block including caudal and epidural use. It is methylparaben-free, sterile, nonpyrogenic, and labeled with Fresenius Kabi USA, LLC. Storage instructions and content details are also visible.*

FDA Label Image

Xyl03 0001 08

Label for Xylocaine-MPF (lidocaine hydrochloride injection, USP) 2% solution, with strength of 40 mg per 2 mL (20 mg per mL). It is labeled for infiltration and nerve block including caudal and epidural use. The package contains a 2 mL single-dose vial and is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

FDA Label Image

Xyl03 0001 09

Label for Xylocaine-MPF 2% (lidocaine HCl injection, USP) 20 mg/mL solution for injection. The single-dose vials contain 2 mL each, providing 40 mg lidocaine per vial. The label indicates use for infiltration and nerve block, including caudal and epidural administration. The product is methylparaben free and is labeled for prescription use only. It is sterile, nonpyrogenic, and manufactured by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.